NWANX
Price
$38.71
Change
-$0.00 (-0.00%)
Updated
Sep 19 closing price
VIVIX
Price
$67.82
Change
-$0.00 (-0.00%)
Updated
Sep 19 closing price
Ad is loading...

NWANX vs VIVIX

Header iconNWANX vs VIVIX Comparison
Open Charts NWANX vs VIVIXBanner chart's image
Nationwide BNY Mellon Dyn US Eq Inc R6
Price$38.71
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Vanguard Value Index I
Price$67.82
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
NWANX vs VIVIX Comparison Chart
Loading...
VS
NWANX vs. VIVIX commentary
Sep 20, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NWANX is a StrongBuy and VIVIX is a StrongSell.

FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 183B vs. NWANX (630M). VIVIX pays higher dividends than NWANX: VIVIX (2.37) vs NWANX (1.71). NWANX was incepted earlier than VIVIX: NWANX (5 years) vs VIVIX (26 years). NWANX is a more actively managed with annual turnover of: 76.61 vs. VIVIX (10.00). NWANX has a lower initial minimum investment than VIVIX: NWANX (1000000) vs VIVIX (5000000). VIVIX annual gain was more profitable for investors over the last year : 20.40 vs. NWANX (16.73).
NWANXVIVIXNWANX / VIVIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence5 years26 years-
Gain YTD15.45615.360101%
Front LoadN/AN/A-
Min. Initial Investment1000000500000020%
Min. Initial Investment IRAN/AN/A-
Net Assets630M183B0%
Annual Yield % from dividends1.712.3772%
Returns for 1 year16.7320.4082%
Returns for 3 years-0.0025.00-0%
Returns for 5 yearsN/A54.23-
Returns for 10 yearsN/A109.21-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EXR181.652.87
+1.61%
Extra Space Storage
CIM16.200.24
+1.50%
Chimera Investment Corp
BCO110.67-0.06
-0.05%
Brink's Company (The)
SGHT6.56-0.27
-3.95%
Sight Sciences
SWAG1.14-0.07
-5.79%
Stran & Company